NUFARM LIMITED (NUF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NUF - NUFARM LIMITED

FNArena Sector : Agriculture
Year End: September
GICS Industry Group : Materials
Debt/EBITDA: 3.53
Index: ASX200 | ASX300 | ALL-ORDS

Nufarm is an Australian agricultural chemicals company with manufacturing and marketing operations in Australia, Asia, Europe and North America. First established in 1956, it became a listed company in 1988.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.65

17 Dec
2024

0.020

OPEN

$3.61

0.55%

HIGH

$3.67

1,701,824

LOW

$3.58

TARGET
$4.208 15.3% upside
OTHER COMPANIES IN THE SAME SECTOR
AAC . AMN . APC . CBO . CXM . D2O . ELD . GNC . HFR . IPL . LGL . MWY . RIC . SGLLV . SHV . TFL . WLD .
FNARENA'S MARKET CONSENSUS FORECASTS
NUF: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx - 6.8 19.1 xxx
DPS (cps) xxx 0.0 5.3 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 19.0 xxx
Dividend Yield xxx N/A 1.4% xxx
Div Pay Ratio(%) xxx N/A 27.6% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/05 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-6.8
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx3,345.9 M
Book Value Per Share xxxxxxxxxxxxxxx513.8
Net Operating Cash Flow xxxxxxxxxxxxxxx472.4 M
Net Profit Margin xxxxxxxxxxxxxxx-0.17 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-1.29 %
Return on Invested Capital xxxxxxxxxxxxxxx-0.17 %
Return on Assets xxxxxxxxxxxxxxx-0.12 %
Return on Equity xxxxxxxxxxxxxxx-0.25 %
Return on Total Capital xxxxxxxxxxxxxxx2.87 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx291.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx82 M
Long Term Debt xxxxxxxxxxxxxxx1,016 M
Total Debt xxxxxxxxxxxxxxx1,098 M
Goodwill - Gross xxxxxxxxxxxxxxx392 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx464 M
Price To Book Value xxxxxxxxxxxxxxx0.77

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx253.0 M
Capex % of Sales xxxxxxxxxxxxxxx7.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,451 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx796 M
Research & Development xxxxxxxxxxxxxxx54 M
Investments - Total xxxxxxxxxxxxxxx64 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

1

xxxxxxx xx xxx xxxx xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

15/11/2024

3

Neutral

$4.50

23.29%

UBS's snapshot of Nufarm's FY24 result suggests the broker believes the challenging report was well known to investors.

EBITDA fell -29%, with a net profit loss of -$4m. Geographically, the results were mixed, with Europe and Seeds performing lower than the broker's forecasts. North America and APAC were better than estimated, and Omega-3 revenue met expectations.

The analyst notes "solid" 2H24 cash flow, which should help alleviate concerns about the balance sheet.

Neutral rated with a $4.50 target price.

Bell Potter

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Wilsons

19/08/2024

3

Market Weight

$3.97

8.77%

Nufarm’s FY24 guidance downgrade is not overly surprising in relation to the crop protection business, Wilsons suggests, given recent peer results, but provides further evidence of the challenge for investors in assessing underlying trends in the business.

The Omega-3 downgrade creates some uncertainty around the interplay between commercial scale-up trajectory and relative pricing dynamic, the broker believes, distracting from the franchise’s game-changer potential.

Wilsons notes that the valuation for Development Seeds has the potential to increase dramatically, but remains conditional on the trajectory of commercial scale-up in the respective franchises.

Target falls to $3.97 from $4.86, Market Weight retained.

FORECAST
Wilsons forecasts a full year FY25 dividend of 4.00 cents and EPS of 12.30 cents.

NUF STOCK CHART